Translating biomarkers by CRC
Tuesday, 22 July, 2008
A new Co-operative Research Centre (CRC) for Biomarker Translation has been officially opened at La Trobe University in Melbourne.
The CRC will investigate the discovery, development, clinical and diagnostic efficacy and commercialisation of new technologies for diagnostic and therapeutic applications.
Partners include La Trobe and the Burnett Institute in Melbourne; the Mater Medical Research Institute in Brisbane; the Institute of Medical and Veterinary Science in Adelaide; US biotech Amgen and scientific supplier Becton Dickinson (BD).
The CRC has received $30 million in cash funding from the Federal Government, $6 million from participants, and more than $100 million in-kind funding from its partners over seven years.
Expertise includes cell surface science, mass spectrometry, monoclonal antibody development, antibody-based diagnostics and clinical immunotherapy.
The CRC's chief scientific officer is immunologist Professor Heddy Zola, director of the Women's and Children's Health Research Institute in Adelaide. The CEO is Michael Kleinig.
Melatonin helps to prevent obesity, studies suggest
In an experiment carried out in rats, chronic administration of melatonin prevented obesity to a...
Personality influences the expression of our genes
An international research team has used artificial intelligence to show that our personalities...
Pig hearts kept alive outside the body for 24 hours
A major hurdle for human heart transplantation is the limited storage time of the donor heart...
